Humana
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 4 in the most recent period (2026/Q4).
- Total institutional ownership (as a % of shares) was little changed.
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 98.58% -0.03pp
- Institutions
- 1,197 -4
- As of
- 2026/Q4 vs. prior period
Holder types
Top holders as of 2026-09-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 33 buys · 12 sells
| Name | Role | Stake |
|---|---|---|
| Frank D'Amelio | Independent Director | 0.02% |
| Kurt Hilzinger | Independent Chairperson | 0.02% |
| James Rechtin | Chief Executive Officer | 0.01% |
| Vishal Agrawal | Former Chief Strategy & Corporate Development Officer | 0.01% |
| Susan Diamond | Former Chief Financial Officer | 0.01% |
| George Renaudin | Strategic Advisor | 0.01% |
| David Dintenfass | President of Enterprise Growth | 0.01% |
| Joseph Ventura | Chief Legal Officer | 0.00% |
| Celeste Mellet | Chief Financial Officer | 0.00% |
| Jorge Mesquita | Independent Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-09 | Wayne Frederick | Independent Director | Open Market Disposition | -440 | $440.58 |
| 2026-11-09 | David Dintenfass | President of Enterprise Growth | Other Disposition | -230 | -- |
| 2026-11-08 | Joseph Ventura | Chief Legal Officer | Other Disposition | -437 | -- |
| 2026-11-08 | Joseph Ventura | Chief Legal Officer | Open Market Disposition | -5,495 | $433.85 |
| 2026-09-29 | Kurt Hilzinger | Independent Chairperson | Other Derivative Acquisition | +238 | -- |
| 2026-08-31 | Shantanu Nundy | Chief Medical Officer | Other Acquisition | +2,549 | -- |
| 2026-08-30 | Shantanu Nundy | Chief Medical Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-07-31 | Frederick John Crawford | Independent Director | Other Acquisition | +544 | -- |
| 2026-07-31 | Paul Smith | Independent Director | Other Acquisition | +544 | -- |
| 2026-07-27 | Frederick John Crawford | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-07-27 | Paul Smith | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-06-29 | Kurt Hilzinger | Independent Chairperson | Other Derivative Acquisition | +233 | -- |
| 2026-04-30 | Joseph Ventura | Chief Legal Officer | Other Acquisition | +10,318 | -- |
| 2026-04-30 | Sanjay Shetty | President of CenterWell | Other Acquisition | +9,945 | -- |
| 2026-04-30 | Celeste Mellet | Chief Financial Officer | Other Acquisition | +15,387 | -- |
| 2026-04-30 | James Rechtin | Chief Executive Officer | Other Acquisition | +35,633 | -- |
| 2026-04-30 | Michelle O’Hara | Chief Human Resources Officer | Other Acquisition | +10,485 | -- |
| 2026-04-30 | David Dintenfass | President of Enterprise Growth | Other Acquisition | +11,273 | -- |
| 2026-04-30 | Japan Mehta | Chief Information Officer | Other Acquisition | +9,448 | -- |
| 2026-04-30 | Aaron Martin | President of Insurance Segment | Other Acquisition | +8,206 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:01:19 · For reference only, not investment advice and not tailored to your situation.
Humana discussion 0 comments